BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15113982)

  • 1. Rash associated with piperacillin/tazobactam administration in infectious mononucleosis.
    LeClaire AC; Martin CA; Hoven AD
    Ann Pharmacother; 2004 Jun; 38(6):996-8. PubMed ID: 15113982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperacillin/tazobactam-induced paresthesiae.
    Lambourne J; Kitchen J; Hughes C; Merry C
    Ann Pharmacother; 2006 May; 40(5):977-9. PubMed ID: 16622157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperacillin/tazobactam--induced petechial rash.
    Abate G; Godbole K; Springston C
    Ann Pharmacother; 2010; 44(7-8):1345-6. PubMed ID: 20571103
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid-Onset Thrombocytopenia Following Piperacillin-Tazobactam Reexposure.
    Nguyen VD; Tourigny JF; Roy R; Brouillette D
    Pharmacotherapy; 2015 Dec; 35(12):e326-30. PubMed ID: 26684560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute generalized exanthematous pustulosis: a rare clinical entity with use of piperacillin/tazobactam.
    Talati S; Lala M; Kapupara H; Thet Z
    Am J Ther; 2009; 16(6):591-2. PubMed ID: 19352142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
    Burgess LD; Drew RH
    Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperacillin/tazobactam-induced immune-mediated thrombocytopenia in the intensive care unit.
    Boyce K; Brar H; Stabler SN
    J Clin Pharm Ther; 2016 Dec; 41(6):730-732. PubMed ID: 27670947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital.
    Oztoprak N; Piskin N; Aydemir H; Celebi G; Akduman D; Keskin AS; Gokmen A; Engin H; Ankarali H
    Jpn J Clin Oncol; 2010 Aug; 40(8):761-7. PubMed ID: 20427546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed drug eruption caused by piperacillin-tazobactam.
    Santosa A; Teo BW; Shek LP
    J Investig Allergol Clin Immunol; 2013; 23(2):132-3. PubMed ID: 23654084
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime.
    Gomes DM; Smotherman C; Birch A; Dupree L; Della Vecchia BJ; Kraemer DF; Jankowski CA
    Pharmacotherapy; 2014 Jul; 34(7):662-9. PubMed ID: 24753221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspected acute interstitial nephritis induced by piperacillin-tazobactam.
    Pill MW; O'Neill CV; Chapman MM; Singh AK
    Pharmacotherapy; 1997; 17(1):166-9. PubMed ID: 9017778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fever and Reversible Laboratory Abnormalities Associated with Prolonged Use of Piperacillin-Tazobactam in Children.
    Patel A; Mao KR; McNeil JC; Kaplan SL; Vallejo JG
    Pediatr Infect Dis J; 2015 Aug; 34(8):849-50. PubMed ID: 25961892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperacillin-Tazobactam Induced Interstitial Nephritis, Hepatitis and Serum Sckness-Like Illness.
    Kraleti S; Khatri N; Jarrett D
    J Ark Med Soc; 2016 Jun; 112(14):278-80. PubMed ID: 27434982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrolytes imbalance: a rare side effect of piperacillin/ tazobactam therapy.
    Hussain S; Syed S; Baloch K
    J Coll Physicians Surg Pak; 2010 Jun; 20(6):419-20. PubMed ID: 20642978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed-type hypersensitivity reaction to piperacillin/tazobactam in a patient with an infected total knee replacement.
    Song EK; Seon JK; Jeong MS
    J Bone Joint Surg Br; 2010 Nov; 92(11):1596-9. PubMed ID: 21037360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperacillin-induced thrombocytopenia reversed by high-flux hemodialysis in an uremic patient.
    Lin SY; Huang JC; Shen MC; Chuang SH; Lee MH; Chen HC
    Hemodial Int; 2012 Oct; 16 Suppl 1():S50-3. PubMed ID: 23036037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute generalized exanthematous pustulosis caused by piperacillin/tazobactam.
    Grieco T; Cantisani C; Innocenzi D; Bottoni U; Calvieri S
    J Am Acad Dermatol; 2005 Apr; 52(4):732-3. PubMed ID: 15793550
    [No Abstract]   [Full Text] [Related]  

  • 18. Generalized fixed drug eruption to piperacillin/tazobactam and review of literature.
    Kornmehl H; Gorouhi F; Konia T; Fung MA; Tartar DM
    Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature.
    Alzahrani M; Alrumaih I; Alhamad F; Abdel Warith A
    Platelets; 2018 Sep; 29(6):628-631. PubMed ID: 29863943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemolytic anaemia caused by piperacillin-tazobactam.
    Dapper I; Nauwynck M; Selleslag D; Hidajat M; Bourgeois M; Martens P; Wilmer A
    Acta Clin Belg; 2009; 64(6):517-9. PubMed ID: 20101875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.